Department of Ophthalmology (R.A.), Itoh Clinic, Saitama, Japan; Lid and Meibomian Gland Working Group (R.A., S.F., N.M.), Tokyo, Japan; Omiya Hamada Eye Clinic (S.F.), Saitama, Japan; and Department of Ophthalmology (N.M.), Yamaguchi University Graduate School of Medicine, Ube, Japan.
Address correspondence to Reiko Arita, M.D., Ph.D., Itoh Clinic, 626-11 Minaminakano, Minuma-ku, Saitama 337-0042, Japan; e-mail: [email protected]
R. Arita has applied for patents on the noninvasive meibography technique described in this article (Japanese patent registration no. 5281846, U.S. patent publication no. 2011-0273550A1, and European patent publication no. 2189108A1), is a consultant for Japan Focus Corporation (Tokyo, Japan), and has received financial support from TearScience (Morrisville, NC). The other authors have no conflicts of interest to disclose.
A talk based on the content of this article was Presented at the Lid and Meibomian Gland Working Group (LIME) International Meeting, May 4, 2016, Seattle, WA.
